IPO Profile: Roka Bioscience Inc

Company Details

Location: 20 Independence Boulevard, Warren, New Jersey 07059

Phone: (908) 605-4700

Website: http://www.rokabio.com

Business Description: Develops molecular assays and instrument systems for food safety industry

Investment & Return Details

VC backers: Aisling Capital LLC, New Enterprise Associates, Inc., OrbiMed Advisors LLC, TPG Growth LLC

Investment Dates: 09/14/2009, 05/17/2011, 12/28/2011, 11/30/2012, 06/18/2013, 09/30/2013, 12/04/2013

Total Funding To Date (USD Mil): $124.22

Value of VCs’ shares at IPO price (USD Mil): $1,262.17

Total return to VCs at IPO price: 10.16x

Shares Beneficially owned by VCs at Offering:

• Aisling Capital LLC: 10,919,518
• New Enterprise Associates, Inc: 31,321,611
• OrbiMed Advisors LLC: 33,801,612
• Tpg Growth LLC: 29,137,708
• Total: 105,180,449

Value of VC shares at IPO price (USD Mil):

• Aisling Capital LLC: $131.03
• New Enterprise Associates, Inc: $375.86
• OrbiMed Advisors LLC: $405.62
• Tpg Growth LLC: $349.65
• Total: $1,262.17

IPO Details

Primary Exchange: Nasdaq

Ticker: ROKA

Time to Exit (Years): 4.8

Date Filed: 05/21/2014

Date Issued: 07/16/2014

Offer Price (USD): $12.00

First Day Closing Price (USD): $12.00

No. of Shares Offered + Overallot Sold All Mkts: 5,000,000

Proceeds Amt + Overallot Sold All Markets (USD Mil): $60.00

Post Offer Value (USD Mil): $211.58

Issuer’s Legal Advisor: Lowenstein Sandler PC

Book Runner: Bank of America Merrill Lynch, Leerink Partners LLC

Co-Managers: Cowen & Co, Wedbush Securities, Inc.

Source: Thomson Reuters and company prospectus